Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Voyager Therapeutics
Voyager Therapeutics
Novartis ignites new stage of Voyager pact with $15M capsid deal
Fierce Biotech
Thu, 09/5/24 - 11:28 am
Novartis
Voyager Therapeutics
capsids
gene therapy
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
Voyager doses first patient with anti-tau antibody in Alzheimer’s trial
Clinical Trials Arena
Mon, 05/20/24 - 11:05 am
Voyager Therapeutics
Alzheimer's disease
clinical trials
VY-TAU01
Novartis, Voyager launch another gene therapy mission with $100M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 am
Novartis
gene therapy
Voyager Therapeutics
Huntington's disease
SMA
Top biotech licensing deals of Q1 2023
BioSpace
Thu, 03/30/23 - 11:03 am
biotech
licensing
Moderna Therapeutics
CytomX
Voyager Therapeutics
Neurocrine Biosciences
Kronos Bio
Genentech
Karuna Therapeutics
Goldfinch Bio
Novartis ready to head for deep space with Voyager after a year 'kicking the tires'
Fierce Biotech
Mon, 03/6/23 - 11:41 am
Novartis
Voyager Therapeutics
Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab
Fierce Biotech
Mon, 01/9/23 - 10:34 am
Voyager Therapeutics
Neurocrine
capsids
CNS
Parkinson's Disease
Pfizer pulls trigger on Voyager gene therapy capsid deal, clearing it to fire TRACER at CNS disease
Fierce Biotech
Tue, 10/4/22 - 10:48 am
Pfizer
Voyager Therapeutics
capsids
gene therapy
Ex-Biogen R&D head Sandrock takes the top job at Voyager
Pharmaforum
Tue, 03/22/22 - 10:06 am
Voyager Therapeutics
Biogen
Al Sandrock
R&D
Pharma CEOs
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Motley Fool
Sun, 03/20/22 - 11:03 pm
Pfizer
Novartis
Voyager Therapeutics
AAV capsid
Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact
Fierce Biotech
Tue, 03/8/22 - 10:07 am
Novartis
Voyager Therapeutics
biobucks
gene therapy
AAV gene therapy
Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models
Fierce Biotech
Fri, 11/5/21 - 09:49 am
Parkinson's Disease
Levodopa
gene therapy
Voyager Therapeutics
Bayer
Pfizer agrees $630m deal to harness Voyager’s gene therapy tech
Pharmaforum
Wed, 10/6/21 - 10:46 am
Pfizer
Voyager Therapeutics
gene therapy
FDA says Voyager can trek on as it removes trial hold for Huntington's gene therapy test
Fierce Biotech
Mon, 04/26/21 - 11:15 am
FDA
Voyager Therapeutics
VY-HTT01
gene therapy
Huntington's disease
Neurocrine Terminates Parkinson's Deal with Voyager Following Clinical Hold
BioSpace
Wed, 02/3/21 - 10:57 am
Voyager Therapeutics
Parkinson's Disease
Neurocrine
clinical trials
FDA gene therapy holdups suggest closer scrutiny by agency
BioPharma Dive
Fri, 11/6/20 - 10:07 am
FDA
gene therapy
Sarepta Therapeutics
Voyager Therapeutics
Iovance
Bluebird Bio
Voyager Takes a Hit After FDA Places Hold on Gene Therapy for Huntington's Disease
BioSpace
Tue, 10/13/20 - 11:01 am
Voyager Therapeutics
gene therapy
FDA
Huntington's disease
VY-HTT01
AbbVie cans Voyager Alzheimer’s, Parkinson’s gene therapy pacts
Fierce Biotech
Tue, 08/4/20 - 11:07 am
AbbVie
Alzheimer's disease
Parkinson's Disease
Voyager Therapeutics
Sanofi Genzyme deserts gene therapy developer Voyager Therapeutics
Endpoints
Mon, 06/17/19 - 11:26 pm
Sanofi Genzyme
Voyager Therapeutics
gene therapy
Voyager Shares Take Off on Parkinson's Disease Development Deal
TheStreet.com
Fri, 02/22/19 - 10:11 am
Voyager Therapeutics
gene therapy
AbbVie
Parkinson's Disease
Pages
1
2
next ›
last »